🇺🇸 FDA
Patent

US 11427644

Dual antigen-induced bipartite functional complementation

granted A61KA61K2039/505A61P

Quick answer

US patent 11427644 (Dual antigen-induced bipartite functional complementation) held by Julius-Maximilians-Universitat Wurzburg expires Mon Aug 25 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Julius-Maximilians-Universitat Wurzburg
Grant date
Tue Aug 30 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 25 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
16
CPC classes
A61K, A61K2039/505, A61P, A61P1/04, A61P17/06